From: Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM
Characteristic | Treatment group | p-value | |
---|---|---|---|
cFSRT (n = 35) | hSRT (n = 13) | ||
28 × 180 cGy (80% IDL) EQD2 = 48–51.8 Gy Eq (α/β = 3) | 5 × 450–600 cGy (80% IDL) EQD2 = 33.75–54 Gy Eq (α/β = 3) | ||
Treatment year | 2010 | 2014 | p < 0.001 |
Median (range) | (2004–2015) | (2013–2015) | |
Time from pretreatment neuro-ophthalmologic evaluation to first day of radiation treatment (Median in months) | 3 | 2 | p = 0.487 |